Hematopathology Flashcards

1
Q

MCV

A
  • Mean Cell Volume (MCV): average volume of RBC
  • femlolitres
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MCH

A
  • Mean Cell Hemoglobin
  • pg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MCHC

A
  • Mean Cell Hb Concentration
  • g/dL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

RDW

A
  • RBC Distribution Width -> cell size variation
  • coefficient of variation of RBC vol.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ferritin & TIBC

A
  • whenever ferritin decr, TICB incr
  • TIBC measures Transferrin
  • nl % Transferrin iron sat. = 33%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hemolytic anemias

A
  • RBC lifespan decreased
  • Increased erythropoeitin & erythropoesis
  • Accumulation of Hb breakdown products
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Intravascular hemolysis

A
  • Mechanical injury to vessels: Ex. defective heart valves, microthrombi
  • Complement fixation: Ab-coated RBC
  • Infections: ex. clostridia, malaria, other parasites
  • Sx (Pathoma):
    • Hemoglobinemia
    • Hemoglobinuria
    • Hemosdierinuria
    • decr serum haptoglobin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Extravascular hemolysis

A
  • RBC rendered less deformable: ex. spherocytosis, sickle cell disease
  • RBC rendered foreign: ex. Ab-coated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lab evidence of hemolytic anemia

A
  • PB: normochromic, normocytic anemia; polychromasia
  • BM: erythroid hyperplasia
  • Plasma/serum: incr bilirubin (unconjugated); incr LDH; decr haptoglobin
  • Urine: hemosiderouremia +/- hemoglobinuria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
A

Hereditary spherocytosis

  • intrinsic hemolytic anemias; extravascular predominant
  • AD, highest incidence in N. Europe
  • mutations in RBC membrane proteins
    • ankyrin
    • band 3
    • band 4.2
    • spectrin
  • Morphology: RBC loses ability to deform and becomes spheroid
  • No central area of pallor, normochromic normocytic
  • Etiopath: reduced RBC membrane stability
    • small fragments loss during shear stress
    • RBC become more spherical
    • stuck in splenic sinusoids
    • phagocytosis by splenic macrophages -> splenomegaly
  • Sx: most cases mild to moderate hemolytic anemia
    • infections can induce aplastic or hemolytic crises
  • Complication:
    • cholelithiasis
    • incr risk of aplastic crisis w B19 infection (Pathoma)
  • Dx:
    • incr MCHC
    • incr RDW
    • osmotic fragility test: in 65% of HS cases, red cells lyse prematurely in increasing hypotonic solution
  • Rx: splenectomy
    • anemia resolves
    • spherocytes persists however
    • Howell-Jolly bodies emerge on blood smear (Pathoma)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
A

G6PD Deficiency: pathophys

  • G6PD A- (10% Blacks); variant (mild)
  • G6PD Mediterranean; markedly reduced T1/2 of G6PD
  • X-linked recessive
  • Etiopath: abnormally folded protein susceptible to proteolytic degradation
    • decr G6PD enzyme activities leads to less protection from oxidant stress.
    • oxidation of SH groups on globin of Hb
    • ppt of denatured globin called Heinz bodies (ppt Hg)
    • Glutathione remains in oxidative state; Glutathione needs to be in reduced state to scavenge free radicas -> Bleaching or oxidation of Hb produce Heinz bodies
    • If membrane is less damaged, bite cells, helmet cells, and spherocytes,
    • Both intravascular (predominant) and extravascular hemolysis
  • Sx:
    • acute hemolysis
    • neonatal jaundice (rare and due to RBC degradation & unconjugated bilirubin)
    • chronic low-grade hemolytic anemia
    • back pain (Hb is toxic; Pathoma)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
A

Etiopath:

  • deoxygenated HbS aggregate and polymerize
  • futher deoxygenation causes sickling
  • Predominantly extravascular hemolysis
  • factors affecting sickling
    • amount of HbS present and its interaction w other Hb chains
      • HbF and HbA decr sickling
      • HbC (abnormal, E6K mutation) incr. sickling on Beta-globin
    • Hb concentration
      • dehydration induces sickling
      • presence of alpha-thal decr. sickling
    • Acidity and Low O2 incr. sickling
    • Triggers: high altitude, hypoxia, exercise,

Sx

  • chronic hemolysis
  • hemolytic anemia
  • dactylitis: swollen hands and feet due to vaso-occlusive crisis; common sign in infants (Pathoma)
  • extramedullary hematopoiesis (crew cut skull X-ray)
  • frontal bossing due to hyperplastic BM
  • hypersplenism -> repeated infarction & fibrosis -> autosplenectomy -> prone to infections by encapsulated bacteria
  • incr. bilirubin (jaundice), gallstones

Complications

  • vaso-occlusive crisis
  • acute chest syndrome, stroke, kidney damage, acute infarction of BM
  • aplastic crisis due to B19 and other viral infections; most common cause of death in children
  • sequestration crisis: pooling of blood in spleen
  • autosplenectomy leads to shrunken, fibrotic spleen (Pathoma from this point on )
  • incr risk of infection w encapsulated organisms (Strep pneumoniae)
  • incr risk of S. paratyphi

Dx: based on Hx

  • PB smear showing target cells
  • Hb electrophoresis
  • Prenatal DNA screening
  • Howell-Jolly bodies on blood smear
  • Metabisulfite screen: causes cells with any amount of HbS to sickle (both in trait and disease)

Rx

  • supportive, analgesics, rehydration
  • hydroxyurea to stimulate HbF production
  • folate supplementation
  • bone marrow transplanation
  • penicillin for prophylaxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
A

beta-Thal MAJOR

  • hypochromic microcytic anemia
  • decr survival of RBC and RBC precursor
  • extramedullary hematopoiesis (frontal bossing, hair on end skull)
  • incr iron absorption

Sx

  • beta-thal major: severe transfusion-dependent anemia
  • beta-thal minor: asx mostly
  • beta-thal intermedia: milder variants of 1, severe variants of 2, or 1 combined w alpha-thal

Complications

  • hemosiderosis & 2o hematochromosis
  • congestive cardiomyopathy
  • hepatosplenomegaly due to extravascular hemolysis & extramedullary hematopoiesis
  • growth retardation & death unless given regular blood transfusions

Dx

  • presents @ 6 to 9 mo post-natal
  • Hb levels = 3 to 6 g/dL
  • HbF markedly increases
  • HbA2 nl or increased slightly

Rx

  • iron chelators
  • BM transplantation
  • hydroxyurea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Beta-Thal minor

A
  • asx usually w mild hypochromic microcytic anemia
  • HbF & HbA2 are both incr
  • Important to dx to avoid treating as iron def. anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

alpha-Thal

A
  • silent carrier= 1 alpha-gene deleted
  • alpha-Thal trait= 2 genes deleted
    • SE Asian: alpha/alpha -/-, CIS
    • Africa: alpha/- alpha/i, TRANS
    • only SE Asian alpha-Thal can produce severely affected offsprings
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HbH & Hydrops Fetalis

A
  • HbH=3 alpha-genes deleted
    • HbH actually formed from tetramers of excess beta chains
    • high affinity for O2 -> tissue hypoxia
    • ppt inclusions in older RBC
    • extravascular hemolysis
    • moderate anemia
  • Hydrops fetalis= 4 alpha-genes deleted
    • lethal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

PNH

A
  • x-linked mutation of PIGA
  • Etiopath:
    • PIGA is a GPI normally inhibiting complement;
    • mutations lead to more complementation activation from proteins including CD55/DAF, C59, C8
    • conferring advantage in pt w autoimmune disease
  • Sx:
    • intravascular hemolysis
    • mild to mod anemia
    • prothrombotic state
  • Dx:
    • Hemoglobinemia, hemoglobinuria & hemosiderinuria
    • flow cytometry for CD55/DAF & CD59 (need GPI to link on membrane) on WBC
    • Flaer test
  • Assoc
    • iron deficiency can be a problem
    • aplastic anemia
    • thrombosis; main cause of death (Pathoma)
    • AML or Myelodysplastic syndrome (main lesion of PNH is a mutation in myeloid stem cell)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Hemolytic anemias: extrinsic RBC abnormalities

A

Immune hemolytic anemias (IHA)

  • cold IHA: IgM-mediated disease usually involves intravascular hemolysis
  • warm IHA: IgG-mediated disease usually involves extravascular; results in spherocyted
  • cold hemolysin IHA
  • Dx: direct and indirect Coombs test

Nonimmune hemolytic anemias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

DAT vs IDAT

A
  • DAT: admin. anti-IgG Ab to RBC -> agglutinate
  • IDAT: admin. test RBC w Ab -> agglutinate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Warm Ab IHA

A
  • most common IHA (50 to 75%)
  • 50% idiopathic
  • 50% predisposing diseases: autoimmune (SLE), lymphoma, or drug reactions
    • Drug induces auto-Ab, Ex. Methyldopa
    • Ab binds to drug-membrane complex, Ex. penicillin
  • IgG mosty (smaller)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Cold Agglutinin (Cold Ab) hemolytic anemia

A
  • IgM mostly (bigger)
  • Acute self-limiting hemolysis: mycoplasma pneumonia, CMV, infectious mono, influenza, HIV
  • Chronic hemolysis: idiopathic or lymphoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hemolysis due to mechanical RBC damage

A
  • cardiac valve prostheses
  • micovascular obstruction: microangiopathic hemolytic anemia
  • DIC, malignant HPT, Thrombotic Thrombocytopenic Purpura (TTP) and Hemolytic-Uremic Syndrome (HUS), SLE, disseminated cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Pernicious anemia: Vit B12 deficiency

A
  • B12 absorbed in duodenum
  • Causes:
    • impaired absorption: most common, pernicious anemia, malabsorption, bowel resection
    • increased requirement (rare)
    • decreased intake: vegans
    • pancreatic insufficiency -> less protease to cleave B12-R binder complex (pathoma)
    • Damage to terminal ileum due to Crohn disease or Diphyllobothrium latum (pathoma)
  • Etiopath: Atrophic gastritis -> impaired IF production -> impaired B12 absorption ->-> megaloblastic anemia
  • Sx: neurological deficits (75%)
    • insidious onset -> severe anemia by time of presentation
    • macrocytic anemia w hypersegmented neutrophils
    • glossitis
    • subacute combined degeneration of spinal cord -> due to build up of methylmalonic acid in spinal cord (Pathoma)
  • Dx: methylmalonic aciduria & serum homocysteine
    • Schilling test: inability to absorb oral dose of B12.
    • Reticulocyte response: look for improvement after 5 d parenteral B12 injection.
    • Serum anti-IF ab
    • incr homocysteine
    • incr methylmalonic acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q
A

Megaloblastic anemias

  • Cause: B12 or folate deficiency
  • Etiopath: pernicious anemia (IF), Crohn’s (distal ileum),
  • deficiency results in inadequate DNA synthesis -> defective nuclear maturation w relatively normal RNA & protein synthesis -> nuclear/cytoplasmic asynchrony
  • Dx:
    • PB smear showing pancytopenia
      • macrocytic anema (MCV > 100)
      • decr reticulocytes
      • enlarged hypersegmented neutrophils (>7 lobes)
    • BM findings
      • hypercellular but ineffective hematopoiesis
      • large cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Folic acid deficiency

A
  • Folate absorbed in jejunum
  • Sx: no neuro deficits
    • glossitis
  • Dx:
    • PB & BM both show megaloblastic anemia w macrocytic RBC and hypersegemented neutrophils
    • serology shows incr homocysteine & nl methylmalonic acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q
A

Iron deficiency anemia

Iron transport

  • plasma protein transferrin: 33%
  • normal serum iron: 100 to 120 ug/100ml
  • TIBC: 300 to 350 mg/ml

Lab Dx:

  • CBC: decr. Hb, decr MCV, incr RDW
  • Early stages of iron def. anemia = normocytic (Pathoma)
  • PB: microcytic hypochromic anemia; severe cases -> poikilocytosis w pencil and target cells
  • bigger central pallor;
  • most common cause in US is chronic blood loss from carcinoma or gastrectomy; impaired absorption (dumping syndrome, parasites)
  • Biochem: decr ferritin, decr transferrin sat, decr serum Fe, incr TIBC, incr FEP (free erythrocyte protoporphyrin)
  • Depletion of BM stores: Prussian blue-

Other Dx

  • Koilonychia due iron deficiency anemia
27
Q

Anemia of chronic diseases

A

Most common cause in hospitalised Pt

  • chronic infections: lung abscess, endocarditis
  • chronic immune diseases: rheumatoid arthritis
  • chronic malignancies

Lab Dx:

  • PB: normochromic normocystic anemia but sometimes hypochromic and microcytic
  • Biochem:
    • incr serum ferritin, decr serum Fe, decr TIBC, decr transferrin sat.
    • Hepcidin sequesters iron in storage sites (pathoma)
    • nl or incr Fe stores in BM
    • EPO levels inappropriately low
28
Q
A

Aplastic anemia

  • damage to HSC
  • Congenital: Fanconi’s anemia (rare)
  • Acquired
    • Idiopathic (unknown cause): 65%
    • known causes: 35% of cases (see below)
  • Seen in teens & elderly

Etiologies

  • drugs or chemicals: alkylating agents, CAT, chloropromazine, phenytoin & radiation
  • viral infections: hepatitis (non-A, B, C, D, G), CMV, EBV, HHV-1, 2
  • autoimmune damage

Lab Dx:

  • PB: pancytopenia, normocytic, normochromic, low reticulocytes count (RC)
  • BM: hypocellular; fat takes over, required to rule out leukemias and myelodysplastic syndrome); dry tap so BM biopsy required and Spleen nl size

Sx: neutropenia -> infections; thrombocytopenia -> abnormal bleeding time

Assoc with leukemia & PNH ( small percentage)

29
Q

Other causes of BM failure

A
  • Myelophthisic anemia: leukoerythroblastic blood picture (white & red cells precursors seen in PB) assoc with granulomatous inflammation and metastatic cancer
    • pathologic process that replaces BM, Ex. cancer (Pathoma from this point on)
    • Hematopoiesis impaired, resulting in pancytopenia.
  • Diffuse liver disease: BM hypofunction
  • Chronic renal failure: decr EPO
30
Q

Tests used to evaluate hemostasis

A
  • PLT count: nl=1.5-4x10e5
  • Bleeding time: incr. bleeding time indicates PLT defect
  • PT: extrinsic
  • PTT: common and intrinsic
  • Thrombin time: tests fibrinogen
31
Q

PLT fx abnormalities

A
  • can be congenital or acquired
  • Acquired includes
    • NSAID
    • Uremia and chronic kidney failure
32
Q

Bleeding due to thrombocytopenia

A
  • spontaneous: 2 x 10e4
  • trauma: 2 - 5 x 10e4
  • 4 categories
    • decr PLT production
    • decr PLT lifetime
    • spleen sequestration
    • dilutional
  • General Sx of platelet disorders: small bleeds charactestic of platelet abnormalities ex. petechiae and superficial bleeds
33
Q

Thrombocytopenia: decr production (BM problem)

A
  • General BM defect
  • Aplastic anemia
  • Marrow infiltrates
  • Drug-indced
  • Infections
  • Megaloblastic anemia
  • MDS
34
Q

Thrombocytopenia: decr survival (peripheral problem)

A
  • immune destruction
    • auto-immune: primary ITP or secondary (SLE, lymphoma)
    • iso-immune: post-transfusion, neonatal
    • drug-induced: heparin, septrin (antibiotic), quinidine
    • infection: HIV, CMV, infectious mono
  • non-immune destruction
    • DIC
    • TTP/HUS causing mucus plug
      • TTP: clinical syndrome of fever, thrombocytopenia, microangiopathic hemolytic anemia, transiet neuro deficits and renal failure -> due to decr. ADAMSTS13, which nl cleaves vWF -> large uncleaved vWF leads to abnormal paltelet ahesion (Pathoma)
        • **Schistocytes (helmets) **are hallmark (Pathoma)
      • HUS (hemolytic uremic syndrome): same same but less neuro deficits
        • platelet microthrombi due to **E. coli O157:H7 **-> endothelial damage (Pathoma)
    • Giant hemangiomas
    • microangiopathic hemolytic anemias (mechanical destruction)

Dx labs (Pathoma):

  • incr. bleed time
  • PT/PTT nl
  • anemia w schistocytes (helmet cells)
  • incr megakaryocytes on bm biopsy
35
Q

ITP

A
  • AUTOIMMUNE
  • Ab-bound platelets are consumed by splenic macrophages resulting in thrombocytopenia (ITP)
  • acute (uncommo): children, post-viral, abrupt onset, self-resolving
  • chronic: females 20 to 40 yo, insidious onset of skin +/- mucosal bleeding, rarely resolves spontaneously; may be primary or secondary (SLE)

Chronic ITP lab Dx

  • decr platelets; PB smear may show they are mostly large PLT
  • incr bleeding time; BUT nl PT/PTT
  • auto-Ab against PLT membrane glycoproteins in 80% cases
  • incr megakaryocytes in BM biopsy: Megakaryocytic ITP = peripheral consumption and not BM problem

Rx

  • immunosuppression (steroids)
  • IVIG (Pathoma)
  • splenectomy: will incr platelets but not to nl levels
    • eliminates source of Ab and site of destruction (Pathoma)
36
Q

vWF Disease

A
  • commonest inherited disorder of bleeding
  • over 20 variants
    • type 1: reduced quantity of vWF; 70% of all cases, mild mucosal bleeding
    • type 3: severe deficiency of vWF, affects Factor VIII stability in plasma so Pt presents like hemophilia A
    • type 2: qualitative (functional) abnormality of vWF, 25% of vWF w mild to moderate bleeding

Dx labs:

  • incr bleeding time due deficient platelet adhesion
  • incr PTT due to loss of FVIII stability,
  • nl PT
  • abnormal ristocetin test (Pathoma)
  • Rx: Desmopressin to stimualte WB to release vWF (Pathoma)

Sx

  • Large bleeds: joint bleeds, abdominal bleeds
37
Q

Hemophilia A (Factor VIII def)

A
  • X-linked R
  • Sx: massive bleeds after trauma or surgery (joint bleeds, abdominal bleeds), spontaneous hemorrhages following minimal trauma to joints and muscles.
  • Lab dx:
    • nl platelets, BT, PT
    • prolonged PTT -> Factor VIII specific assay
  • Rx: recombinant FVIII
38
Q

Lymphopenia

A
  • HIV advanced infection
  • autoimmune
  • acute viral infection
  • drug-induced: cytotoxic chemotherapy, steroid therapy
39
Q

Neutropenia

A

Pathogenesis

  • decr or ineffective BM production
    • suppression of committed myeloid precursors: drug-induced
    • rare inherited disorders: Kostmann syndrome)suppression of myeloid stem cells: aplastic anemia, usually idiopathic
    • ineffective granulopoiesis: megaloblastic anemia, myelodysplastic syndromes
    • marrow infiltration: granulomatous inflammation, tumours
  • accelerated consumption/destruction
    • Peripheral loss: immune-related (idiopathic autoimmune disease, drugs), splenic sequestration (splenomegaly), incr consumption (overwhelming infection)

Sx

  • agranulocytosis: severe neutropenia, prone to life-threatening infections (<500 cells/ul)
  • severe neutropenia is most commonly drug-induced
  • signs and sx related to infections
40
Q

Basophilic leukocytosis

A
  • rarely reactive
  • indicates myeloproliferative neoplasm such as CML
41
Q

Lymphocytosis (from infection) and reactive LN

A
  • follicular hyperplasia -> B cells
  • paracortical hyperplasia -> T cells
  • sinus histiocytosis -> dilated sinus
42
Q

Lymphoma clinical presentation

A
  • NHL (60%) and all HL -> non-tender LN enlargement
  • NHL (40%) -> extranodal -> site-related sx
43
Q

Leukemia clinical presentation

A
  • sx related to BM replacement -> cytopenia
44
Q

Plasma cell neoplasia clinical presentation

A
  • bone destruction -> bone pain
45
Q

Lab investigations for lymphoma

A
  • Histology
  • PCR or Southern
  • IHC or flow cytometry for light chain restrictions
46
Q

Follicular lymphoma

A
  • middle age
  • painless lymphadenopathy
  • stage IV at dx w liver and spleen involvement
  • Tumour arises from GC B cells
    • 2 patterns: nodular or mixed nodular & diffuse
    • 2 types of cells: small & large
    • Diffuse and large -> more aggressive
  • Immunophenotype: CD19, CD20, CD10+
  • 90% cases have t(14;18) -> results in overexpression of BCL-2, which inhibits apoptosis
  • indolent but incurable
  • some develop into more aggressive form DLBL

Dx: distinguished from follicular hyperplasia by (Pathoma)

  • disruption of normal LN architecture
  • lack of tingible body macrophages in GC
  • expression of Bcl2 in follicle
  • monoclonality
47
Q

Diffuse Large B-cell lymphoma (DLBL)

A
  • Older people (60 yo)
  • 60% in LN; 40% extranodal (ex. Waldeyer ring)
  • Primary (de novo) or 2o to transformation of a previous low grade follicular lymphoma
  • moderately aggressive tumour; responsive to treatment
  • Sx: B-sx -> fever, night sweats, weight loss
  • Dx: Often stage I or II @ dx with -ve BM
    • CD19+ & CD10+ (Robbins)
48
Q
A
  • CLL is most common adult leukemia (aka Small lymphocytic lymphoma)
  • Sx: cytopenias, enlarged LN, liver or spleen
  • Dx:
    • PB: small, mature lymphocytes & smudge cells (2o to membrane fragility)
      • high WBC count
    • BM: interstitial nodules -> diffuse replacement
    • Immunophenotype: CD19, CD5 & CD20 co-expression, CD23, CD43 +ve
  • C&C:
    • indolent and incurable
    • complication:
      • auto-immune hemolytic anemia
      • transformations to more aggressive neoplasm w larger cells: prolymphocytic leukemia (20%) & DLBL (10%)
      • hypogammaglobinemia -> most common cause of death in CLL due to infections (Pathoma)
    • cause of death: pancytopenia -> infections and bleeding
49
Q

Mantle cell lymphoma (Pathoma only)

A
  • neoplastic small B cells (CD20+) that expand mantle zone
    • expanding region immediately adjacent to follicle
  • clinically present in late adulthood w painless LAD

Etiopath

  • driven by t(11,14)
  • cyclin D1 on chr11 translocates to Ig heavy chain locus on chr14
  • overexpression of cyclin D1 promotes G1/S transition
50
Q

Marginal Zone Lymphoma (aka MALToma)

A
  • Indolent w mostly mature lymphocytes, extranodal
  • MALTS: tonsils, adenoids, Peyer’s patches, stomach
  • most common site for MALToma in stomach from H. pylori
    • other common sites are salivary gland and thyroid gland
    • assoc with chronic inflammatory states including Hashimoto, Sjorgren syndrome (autoimmune)
  • MZL can spread to other mucosal sites
51
Q
A

Burkitt Lymphoma

  • aggressive B-cell lymphoma assoc w EBV

Clinical scenarios

  • African (Endemic) Burkitt -> 100% EBV
    • preferred sites: mandible, ovaries, kidneys, adrenal glands
  • Sporadic Burkitt -> 15% EBV
    • preferred site: ileocecal/abdomen -> obstruction
  • HIV-assoc Burkitt -> 25% EBV

Morphology

  • starry sky appearance from macrophages eating necrotic cell debris from all the cell proliferation.
  • normal looking lymphocytes,
  • Extranodal masses in form of neoplasm growing from mandible (right)
  • t(8;14) -> overexpression of MYC
  • B sx: fever, night sweats, weight loss
  • Investigations: flow cytometry CD19+, CD20+, CD10+, and surface Ig+

C&C rapid growth but responsive to chemotherapy

52
Q
A

Hairy cell leukemia

Morphology

  • Right: Acid Phosphatase (TRAP) stain showing reticulin
  • Hairy cell in PB; fried egg in BM
  • BM with fibrosis so dry tap
  • Accumulates in red pulp of spleen -> sequestration -> Howell-Jolly bodies & beefy red appearance -> splenomegaly
  • Dx
    • Flow: CD20, CD25, CD11c, 103
    • biopsy -> TRAP stain + (mostly for hairy cell leukemia)
  • Sx
    • Middle age males, pancytopenia due to being trapped in reticulin & splenomegaly
    • Rarely LN enlargement; asx or indolent; anemia
53
Q

Range of Plasma Cell Neoplasms

A
  • Multiple myeloma -> IgG
  • Walderstrom agammaglobinemia -> IgM
  • Heavy chain disease -> H chains
  • Primary amyloidosis -> Light chains
  • MGUS
54
Q
A

Multiple myeloma

  • Left: BM w abnormal plasma cells, excess clock face, golgi bodies secreting a lot of Ig
  • Right: Rouleaux formation due high production of Ig causing RBC to stick
  • Germinal centre B-cells acquired mutation -> transformed -> go to sites such as BM to proliferate -> plasma cell neoplasm
  • middle age men w bone pains

Etiopath

  • malignant proliferation of plasma cells in BM
  • high serum IL-6 (important GF for plasma cell)

Sx: CRAB=Calcemia, Renal failure (2o to hypercalcemia, BJ proteins, amyloid), Anemia, Bone lesions

  • cytopenias due to BM replacement
  • organomegaly late in disease (liver, spleen, LN, lungs)
  • bacterial infections: 2o to neutropenia and hypogammaglobinemia (nl IgG low)
  • Dx
    • Serum analysis:
      • hypercalcemia,
      • M spike aka gamma Ig -> monoclonal plasma cells
    • Urine analysis: light chains BJ proteins
      • AL amyloidosis -> myeloma kidney -> renal failure (Pathoma)
55
Q
A

Hodgkin’s lymphoma (HL)

  • Biopsy of LN
  • neoplastic Reed-Sternberg cells (altered germinal centre B-lymphocytes appearing as large B cell w multilobed nuclei) secreting cytokines drawing in reactive/inflammatory cells
  • Less tumour cells (Reed-Steenberg cells), more inflammatory cells
  • Owl eye cells -> inclusion-like
  • Hodgkin lymphoma starts in single node and spread continuously (whereas non-Hodgkin spread is unpredictable)
  • Best prognosis is Hodgkin; younger age group
  • Stages: 1-4
    • Stage I: single LN
    • Stage II: multipe LN involved on same side of diaphragm
    • Stage III: multiple LN involved on both sides of diaphragm
    • stage IV: multiple/disseminated involvement
  • Sx: Most lymphomas lead to hemolytic anemia
    • painless rubbery LN enlargement
    • pain in involved LN after drinking EtOH
    • fever, night sweats, weight loss
    • cutaneous anergy (itching)
  • Dx: HL divided into Classical or Variant HL according to immunophenotype
    • Classical: CD15+, CD30+, CD45-
    • Variant: CD20+, CD45, CD 15-, CD30-
    • Eosinophilia (Pathoma)
  • 2 groups of HL Types:
    • nodular sclerosis (most common)
    • mixed cellularity,
    • lymphocyte-rich,
    • lymphocyte-depleted
    • Variant: lymphocyte-predominant
  • Nodular sclerosis HL
    • mostly adolescents or young adults
    • mediastinal involvement
    • Stage I or II @ presentation (mediastinal +/- neck LN)
    • Large nodules, at least partly surrounded by thick fibrous collagen bands -> fibrosis cuts nodules hence the name
    • Presence of Lacunar R-S cell (type of Reed-Sternberg cell)
  • Mixed cellularity HL
    • diffuse nodal replacement, frequent RS cells, often EBV+
    • young adults & adults >55 yo men
    • systemic sx and advanced stage (ab involvement) at presentation
    • assoc w eosinophilia (Pathoma)
  • Lymphocyte depleted HL
    • abundant RS cells that may be bizarre & very often EBV+, background of few lymphocytes and fibrosis
    • elderly of HIV+ w systemic sx and advanced stage IV @ presentation.
  • Variant HL
    • large nodules (but no collagen band fibrosis)
    • L&H or popcorn cell (a type of Reed-Sternberg)
    • Young men < 35 yo
    • cervical or axillary nodes
    • indolent behaviour but tendency to recur
    • <5% transform to a non-HL large B-cell lymphoma
  • Rx & Prognosis:
    • Radiation +/- multi-agent chemo depending on clinical stage.
    • stage is the most important prognostic indicator
    • 5YDFS
      • Stage I & II=90%
      • Stage IV=60 to 70%
  • C&C: long term survivors get 2o cancers including AML, lung cancers.
56
Q
A

ALL

  • 85% ALL cases are pre-cursor B-cell types -> Childhood
  • 15% ALL cases are T-cell neoplasms presenting as mediastinal masses -> Adolescent males
  • Left image: Marked incr in lymphoblasts; mutations in genes involved in differentiation (TF) married w complementary mutations in genes involved in proliferation (MYC-ABL)
  • Right image: PAS stain to ddx ALL from AML. ALL will show clear (agranular) cytoplasm; no Auer rods,
  • Cytogenetics: 90% of ALL have hyperdiploidy (favourable prognosis) or translocation
  • Sx: Abrupt onset and severe (short history of sx)
    • bleeding problems -> petechiae, bruising, epistaxis
    • cytopenias (and their sequelae), bone pain
    • generalised enlargement of LN, liver, spleen
    • thymic enlargement (T-ALL)
    • testicular enlargement (B-ALL)
    • CNS involvement (B-ALL): headaches, blurred vision, vomiting
  • Dx: tdt marker in nucleus (Pathoma)
    • B-ALL surface markers: CD10, CD19, CD20
    • T-ALL surface markers: CD2 to CD8 (Blasts do no express CD10)
  • Rx: multi-agent chemotherapy w prophylactic chemo to scrotum and brain; Bone marrow transplant (BMT) for relapsed cases
    • Prognostic factors: see image

Assoc diseases: Down syndrome after age of 5

57
Q
A

AML

  • adults and old people (>60 yo)
  • Sx: Acute onset (weeks-months), sx related to cytopenias
  • Tissue involvement can be a feature of AML w monocytic differentiatiion.
    • Ex. skin=funny rash;
    • mucosal=gum swelling
  • AML: FAB classification
    • Degree of maturation of granulocytic lineage of AML (M0 to M3)
    • Presence of additional lineages of blast cell (M4 to M7)
  • Chromosomal translocations
    • younger adults w de novo AML such as promylocytic leukemia: t(15:17) aka RXR mutation & AMLM3
      • Complication: Auer rods & granules inducing DIC
      • most translocations -> better prognosis except those having chr 11
  • Deletions & monosomy on chr 5 & chr 7
    • Precursor syndrome: older people w AML w myelodysplasia (MDS) or post-chemo/radiotherapy
  • Etiopath:
    • mutations similar to ALL
    • alkylating agents or radiotheraphy resulting in myelodysplastic disorder which can progress to AML
  • Sx: rapid onset of sx of cytopenias
    • anemia
    • neutropenia: fever, sepsis
    • thrombocytopenia: spontaneous mucosal, skin, intracranial bleeds
    • M4 & M5 complication: skin and mucosal manifestations -> skin rashes, bleeding from gums (acute monoblastic leukemia), monocytes
    • extramedullary masses (uncommon)
    • hepataosplenomegaly: mild, if present
  • Lab Dx:
    • PM smear showing circulating blasts
    • occasionally, aleukemic leukemia
    • MPO stain -> aggregates called Auer rods
    • BM aspirate & biopsy (Gold standard) > 20% blasts in BM
    • Flow cytometry: expression of myeloid markers
    • Cytogenetics
  • Rx and Prognosis
    • In AML w t(15;17), the chimeric RARalphaPML -> block of differentiation -> so Trans-retinal to differentiate cells to neutrophils.
    • most AML given combination chemo
      • t(8;21) & inv 16 = better
      • t(15;7) = intermediate
      • del 5 or 7 = poor
    • BMT for high risk
  • C&C: Acute megarkyoblastic leukemia emergency due to risk of DIC (Pathoma)
58
Q

Myelodysplastic syndromes (MDS)

A
  • Clonal maturational defect leading to:
    • ​ineffective hematopoiesis
    • cytopenias
  • Clinical settings:
    • ​idiopathic: >50 yo & gradual onset
    • therapy-related: 2 to 8 yo, post-chemo or radiation therapy
  • Outcome: transformation to AML (10 to 40% of cases), or death related to complication of cytopenias.
  • PB: macrocytic anemia, cytopenias, +/- blast cells
  • BM: usually hypercellularity but ineffective hematopoiesis​
    • abnormally shaped RBC, granulocytic precursors, and megakaryocytes.
  • Course & complications:
    • in severe MDS, blast cells increased but by definition <20% of total cells.
  • ​Dx:
    • cytopenias causing anemia (macrocytic & usually persistent and unexplained on presentation), neutropenia, thrombocytopenia
    • PB and BM morphology
    • cytogenetics
    • flow cytometry
    • 5q deletions marker for post-therapy myelodysplasia (Robbins)
  • Rx:
    • BMT for younger, supportive for older
59
Q

Chronic Myeloproliferative Neoplasms

A
  1. CML
  2. Polycythemia Vera
  3. Essential Thrombocytosis (ET)
  4. Primary Myelofibrosis (PM) -> megakaryocytes

Note: All have JAK2 mutations except CML which has the MYC-AB: translocation

  • Disorder to pluripotent progenitor cells, capable of uncontrolled proliferation w full differentiation.
  • Tumour cells circulate and home in on 2o sites of hematopoiesis in organs -> spleen & liver organomegaly
  • PB smear image:
  • Myelocytes at numerous stages of differentiation
  • More granular mylocytes -> megakaryocyte
  • Termination in a spent phase of progressive BM fibrosis and cytopenias (PV, ET, MF) or transformation to acute leukemia.
  • Sx: slow onset, organomegaly

Complications (Pathoma):

  • incr risk of hyperuricemia (except in ET)
  • progression of marrow fibrosis
  • transformation to acute leukemia
60
Q
A

CML (type of CMP): specific features

  • 100% of cases have t(9;22) ; Philadelphia chromosome acquired at stem cell stage.
  • mainly granulocytic
  • 25 to 60 yo men
  • PB smear image:
    • striking left shift of leukocytosis, mostly neutrophils, metamyelocytes, and myelocytes, and eosinophils and basophils (basophilia)
    • sometimes thrombocytosis
  • BM: mostly granulocyte precursors w incr megakaryoctyes
  • Sx: Gradual onset
    • tiredness, weakness, loss of weight and appetite
    • Enlarging spleen can lead to ab discomfort

Dx (Pathoma)

  • DDx w infection which also show incr granulocytes
  • CML granulocytes are Leukocyte Alkaline Phosphatase (LAP) -ve, i.e. leukemoid reaction -ve
  • CML assoc w incr basophils
  • CML granuloctyes exhibit t(9,22)

Course & complications:

  • Stable phase: 3 y w 50% progressing to accelerated
  • Accelerated: incr blasts, BM fibrosis, thrombocytopenia, and incr. cytogenetic abnormalities -> transformation to acute leukemia
  • Blast crisis: looks like acute leukemia, left shift to stem cell stage, then 75% myeloid and 25% lymphoid stages

Rx:

  • Imantinib (Gleevec) slows down TK activity of BCR-ABL translocation
  • IFn-alpha
  • Hydroxyurea: gentle chemo
  • BMT
61
Q

Myelofibrosis

A

Myelofibrosis

  • Left image: BM showing extensive reticular fibrosis
    • Dysplastic megakaryocytes in clusters
    • Distended marrow sinusoids, frequently containng intravascular hematopoiesis.
  • Right image: BM reticulin stain for collagen III
    • incr thickening of reticulin fibres; dense network of fibres
    • proliferation of fibroblasts & deposition of collage w/in BM
  • Image below: leukoerythroblastosis
    • Tear-drop shape of dacryocyte, characteristic of myelofibrosis.
  • Primary Myelofibrosis (aka Myeloid metaplasia):
    • type of myeloproliferative disorder.
    • hyperproliferation of neoplastic myeloid progenitors that retain capacity for terminal differentiation.
    • Leads to incr in one or more formed elements of PB
  • MPL or JAK kinase mutations (1o myelofibrosis)
  • A lot of megakaryocyte -> secrete PDGF -> fibroblasts laid down in BM
  • Sx: anemia, splenomegaly (extramedular hematopoiesis), leukoerythroblastic smear
  • Dx: Dry tap on BM aspirate
  • Course & complications:
    • incr risk of infection, thrombosis, bleeding hemorrhagic episodes
    • hyperurecemia, and gout due to rapid cell turnover
62
Q
A

Infectious mono

Morphology

  • Arrow is pointing to atypical large lymphocytes called Downey cells
  • Enlarged reactive CD8 T lymphocytes with increased cytoplasmic: nucleus ratio. Arrow is pointing to a phenomenon called “Dutch/Ballerina Skirt”. Nucleus of Lymphocytes in basophilic and peripherally located.

Etiopath

EBV spread via saliva→ virus invades and replicates inside epithelial cells of nasopharynx→ immune system response via CD­8+ cells → symptoms (4­8wks after infec)

Sx

  • Fever
  • lymphadenopathy (cervical, axillary and inguinal)
  • sore throat
  • hepatosplenomegaly (T­ cell hyperplasia)
  • Splenomegaly -> periarterial lymphatic sheath (PALS); in white pulp (Pathoma)

Dx

  • Serology: look for Ab against EBV/CMV,
  • Heterophile-positive (Monospot) test
    • Monospot test positive in EBV and negative in CMV
    • employs heterophile Ab ->Latex agglutination assay -> reactive to sheep and donkey sera)
  • lymph node biopsy­ find hyperplasia of paracortex (immature + mature T cells).

C&C

  • incr risk of splenic rupture -> avoid contact sports
  • rash if exposed to penicillin
  • dormancy of virus conferring increased risk of lymphoma

● Lymphocyte depleted hodgkin’s lymphoma

● Burkitt’s Lymphoma (NHL)

● Nasopharyngeal carcinoma

● Oral hairy leukopenia

63
Q

Polycythemia Vera

A
  • Relative polycythemia: due to reduced plasma volume (usually 2o to dehydration).
  • Absolute polycythemia:
  • Primary – Polycythemia Vera (PRV), a chronic myeloproliferative neoplasm.
  • Secondary –

(a) Appropriately high EPO levels – lung disease, cyanotic heart disease, living at high altitude.
(b) Inappropriately high EPO levels – EPO secreting tumors (e.g. kidney & liver cancers)

Sx

  • blurry vision and headache
  • incr risk of venous thrombosis -> Budd-Chiari syndrome (hepative v. thrombosis)
  • flushed face due to congestion
  • itching after bathing from Mast cells releasing histamine